RT @jsross119: Erick's paper demonstrates. Reporting biases are diminished for newer vs older antidepressants! Bonus content, (ICYMI) we've…
Erick's paper demonstrates. Reporting biases are diminished for newer vs older antidepressants! Bonus content, (ICYMI) we've also examined FDAAA's impact for various drug classes & medical devices (2/2) https://t.co/kG4u5QAgbN, https://t.co/TCCmbksQ2C,
We had previously shown that FDAAA was associated with higher rates of trial registration and results reporting on https://t.co/ickEwc8kA2 and significantly lower degrees of publication bias for drug trials (2/5) https://t.co/5dpAXjVVN7 and https://t.co/TC
RT @AllenFrancesMD: Very Good News: New study shows #pharma is now less able to hype positive results & hide negative studies. https://t.co…
Very Good News: New study shows #pharma is now less able to hype positive results & hide negative studies.
Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study https://t.co/Lnnsen54Xx #trialsjournal
@US_FDA Amendments Act (2007) resulted in higher #trial #registration and #reporting and less #publication #bias in #neuropsychiatric drugs #TrialsJournal @MedicalEvidence (open access). #RCTs https://t.co/wiMQyqsLs9 https://t.co/gj9NlUfKHU
RT @EvanMayoWilson: Important evidence from @cxzou1 and colleagues that FDAAA has increased data availability and reduced publication bias…
RT @MedicalEvidence: Registration, results reporting & publication bias of clinical trials supporting FDA approval of neuropsychiatric drug…
RT @jsross119: Out today, FDAAA mandated clinical trial registration and results reporting requirements associated with higher rates of bot…
Great! Really great!
Artigo aborda o registro, relatórios de resultados e viés de publicação de ensaios clínicos apoiando a aprovação pelo FDA de drogas neuropsiquiátricas antes e depois do "Amendments Act", aprovado em 2007. Leia em https://t.co/cLiafIt6Bh
Registration, results reporting & publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before & after FDAAA - a retrospective cohort study via #Trialsjournal: https://t.co/beubrJBrFk
RT @jsross119: Out today, FDAAA mandated clinical trial registration and results reporting requirements associated with higher rates of bot…
RT @EvanMayoWilson: Important evidence from @cxzou1 and colleagues that FDAAA has increased data availability and reduced publication bias…
RT @jsross119: Out today, FDAAA mandated clinical trial registration and results reporting requirements associated with higher rates of bot…
RT @jsross119: Out today, FDAAA mandated clinical trial registration and results reporting requirements associated with higher rates of bot…
Negative results more likely to get published post FDAAA. Not surprised. Thanks for sharing @jsross119
RT @hildabast: Before & after FDAAA (trial reporting legislation) for 37 new neuropsych drugs FDA-approved 2005-2014, based on 101 pre-FDAA…
RT @hildabast: Before & after FDAAA (trial reporting legislation) for 37 new neuropsych drugs FDA-approved 2005-2014, based on 101 pre-FDAA…
RT @EvanMayoWilson: Important evidence from @cxzou1 and colleagues that FDAAA has increased data availability and reduced publication bias…
RT @jsross119: Out today, FDAAA mandated clinical trial registration and results reporting requirements associated with higher rates of bot…
RT @jsross119: Out today, FDAAA mandated clinical trial registration and results reporting requirements associated with higher rates of bot…
Promising results from @cxzou1 et al: for trials supporting FDA approval of new drugs for neuropsychiatric indications, the proportions of trials registered & reporting results on https://t.co/yxwqaPuZfT were higher & publication bias was lower aft
RT @jsross119: Out today, FDAAA mandated clinical trial registration and results reporting requirements associated with higher rates of bot…
RT @jsross119: Out today, FDAAA mandated clinical trial registration and results reporting requirements associated with higher rates of bot…
RT @jsross119: Out today, FDAAA mandated clinical trial registration and results reporting requirements associated with higher rates of bot…
Out today, FDAAA mandated clinical trial registration and results reporting requirements associated with higher rates of both for neuropsych trials supporting FDA approvals, lower likelihood of selective publication and outcome reporting) https://t.co/5dpA
Before & after FDAAA (trial reporting legislation) for 37 new neuropsych drugs FDA-approved 2005-2014, based on 101 pre-FDAA trials & 41 post-FDAA. Trial registration ⬆️ .. trial publication ⬆️ .. misleading interpretations ⬇️ .. publication bias ⬇